Insulin therapies

NPH insulin, also known as isophane insulin (INN) and by , is an intermediate-acting insulin given to help control the blood sugar level of people with diabetes.

Insulin (medication) is the use of insulin and similar proteins as a medication to treat disease.

The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentration of a sugar called glucose in the blood.

The complications of diabetes mellitus are far less common and less severe in people who have well-controlled blood sugar levels.

Ketoacidosis is a metabolic state associated with high concentrations of ketone bodies, formed by the breakdown of fatty acids and the deamination of amino acids.

Blood glucose monitoring is a way of testing the concentration of glucose in the blood (glycemia).

Fluorescent glucose biosensors are devices that measure the concentration of glucose in diabetic patients by means of sensitive protein that relays the concentration by means of fluorescence, an alternative to amperometric sension of glucose.

Glucagon rescue is the emergency injection of glucagon in case of severe diabetic hypoglycemia.

Insulin degludec (INN/USAN) is an ultralong-acting basal insulin analogue that was developed by Novo Nordisk under the brand name Tresiba.

Insulin aspart is a fast-acting insulin analog marketed by Novo Nordisk as NovoLog/NovoRapid.

Insulin lispro (marketed by Eli Lilly and Company as Humalog) is a fast acting insulin analog.

Insulin detemir is a long-acting human insulin analogue for maintaining the basal level of insulin.

Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes.

Regular insulin includes regular human insulin also known as human insulin (regular) and is a short acting insulin.

Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid.